Literature DB >> 9885106

Treatment of advanced heart failure in a young man with familial cardiomyopathy.

E K Massin1.   

Abstract

We report the case of a young man with familial cardiomyopathy whose symptoms became difficult to control as his myopathy worsened. He had persistent cardiac arrhythmias and was intolerant of angiotensin-converting enzyme inhibitor therapy. His case illustrates the difficulties that can be encountered in treating patients with advanced heart failure.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9885106      PMCID： PMC325575     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  15 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

3.  Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.

Authors:  G C Fonarow; C Chelimsky-Fallick; L W Stevenson; M Luu; M A Hamilton; J D Moriguchi; J H Tillisch; J A Walden; E Albanese
Journal:  J Am Coll Cardiol       Date:  1992-03-15       Impact factor: 24.094

4.  Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy.

Authors:  T Meinertz; T Hofmann; W Kasper; N Treese; H Bechtold; U Stienen; T Pop; E R Leitner; D Andresen; J Meyer
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

5.  Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis.

Authors:  P T Vaitkus; E S Barnathan
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

6.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

Authors:  J Siebels; K H Kuck
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

7.  Ventricular arrhythmias in idiopathic dilated cardiomyopathy.

Authors:  K von Olshausen; A Schäfer; H C Mehmel; F Schwarz; J Senges; W Kübler
Journal:  Br Heart J       Date:  1984-02

8.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

9.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

10.  Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography.

Authors:  J Holmes; S H Kubo; R J Cody; P Kligfield
Journal:  Am J Cardiol       Date:  1985-01-01       Impact factor: 2.778
View more
  1 in total

Review 1.  Disease causing mutations of troponin alter regulated actin state distributions.

Authors:  Joseph M Chalovich
Journal:  J Muscle Res Cell Motil       Date:  2012-06-08       Impact factor: 2.698
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.